Impact of Tardive Dyskinesia on Caregivers’ Well-Being and Daily Life
A team of investigators sought to assess the impact of patients’ symptoms of tardive dyskinesia on the individuals caring for them.
All articles by Psychiatry Advisor Contributing Writer
Severity of Major Depressive Disorder Influences Direct and Indirect Healthcare Costs
Investigators examined healthcare costs of adult patients with mild, moderate, moderately severe, and severe major depressive disorder and compare them with a control group representative of the general population.
Patient Priorities for Medication Management Strategies for Serious Mental Illnesses
Researchers conducted web-based focus groups to better understand patient preferences for medication management of a serious mental illness.
Mental Health Needs Increased Significantly During the COVID-19 Pandemic
Investigators share outcomes from a virtual roundtable convened to discuss the effect of the COVID-19 pandemic on mental health and psychiatric care delivery.
Telehealth a Barrier to Management of Drug-Induced Movement Disorders
Investigators participating in the TeleSCOPE study deployed a survey to evaluate the management of drug-induced movement disorders via telehealth during the COVID-19 pandemic.
Earlier Onset of Adverse Childhood Events Linked With Worse Adulthood PTS Symptoms
Investigators assessed the impact of early-onset adverse childhood events on thalamic volume and subsequently the development of PTSD after trauma in adulthood.
Huntington Disease May Be Undertreated and Current Monotherapies Inadequate
Investigators used data from the Enroll-HD registry to assess patterns of treatment for chorea in patients with Huntington disease.
Paliperidone Linked to Better Outcomes Than Oral Antipsychotic Agents for Schizophrenia
Researchers assessed adherence to treatment and hospital readmission rates in patients undergoing treatment with oral antipsychotics vs LAI paliperidone for schizophrenia.
Adjunctive Bexpiprazole May Help Individuals With Symptoms of Anxious Distress
A team of investigators sought to assess the efficacy of brexpiprazole as an adjunct to antidepressant treatment in patients with major depressive disorder and anxious distress.
Long-Acting Injectable Agents May Help Reduce Downstream Medical Costs, Resource Use for Schizophrenia
A team of investigators assessed medical resource utilization among patients treated with either oral or long-acting injectable antipsychotic agents for schizophrenia.
- Loading...
Loading...
Next post in Psych Congress 2021
Loading... 
Loading...